July 7, 2015
Opdivo-Yervoy Combination Results Appear in Front-Page of ASCO Daily News A development race for immune checkpoint inhibitors is heating up between five camps of drug makers - Bristol-Myers Squibb (BMS)/Ono Pharmaceutical, US Merck & Co., AstraZeneca, Roche, and German Merck...read more